GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » Notes Receivable

Sipai Health Technology Co (HKSE:00314) Notes Receivable : HK$0 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co Notes Receivable?

Sipai Health Technology Co's Notes Receivable for the quarter that ended in Jun. 2024 was HK$0 Mil.


Sipai Health Technology Co Notes Receivable Historical Data

The historical data trend for Sipai Health Technology Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sipai Health Technology Co Notes Receivable Chart

Sipai Health Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial - - - - -

Sipai Health Technology Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sipai Health Technology Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Sipai Health Technology Co Notes Receivable Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Sipai Health Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
Executives
Impresa Management Llc
Eight Roads Holdings L.p. 2201 Interest of corporation controlled by you
Eight Roads Management Limited 2201 Interest of corporation controlled by you
Crow Lane Limited 2201 Interest of corporation controlled by you
Cliff Trail Llc 2201 Interest of corporation controlled by you
Impresa Fund Iii Limited Partnership
Pandanus Partners L.p.
Fil Limited
Fmr Llc
Johnson Abigail P.
Johnson Iv Edward C.
Pandanus Associates Inc.
Eight Roads Shareholdings Limited
Chang Jimmy Ching-hsin 2201 Interest of corporation controlled by you
Purple Panther 2201 Interest of corporation controlled by you

Sipai Health Technology Co Headlines

No Headlines